{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["3G", "K562", "apoptosis", "cell cycle", "leukemia", "mikanolide derivatives", "sesquiterpene"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35721186", "DateRevised": {"Year": "2022", "Month": "07", "Day": "16"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "05", "Day": "20"}], "Language": ["eng"], "ELocationID": ["809551", "10.3389/fphar.2022.809551"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "13", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Design, Synthesis, and Antileukemic Evaluation of a Novel Mikanolide Derivative Through the Ras/Raf/MEK/ERK Pathway.", "Pagination": {"StartPage": "809551", "MedlinePgn": "809551"}, "Abstract": {"AbstractText": ["Chronic myeloid leukemia (CML) accounts for a major cause of death in adult leukemia patients due to mutations or other reasons for dysfunction in the ABL proto-oncogene. The ubiquitous BCR-ABL expression stimulates CML by activating CDK1 and cyclin B1, promoting pro-apoptotic, and inhibiting antiapoptotic marker expression along with regulations in RAS pathway activation. Thus, inhibitors of cyclins and the RAS pathway by ERK are of great interest in antileukemic treatments. Mikanolide is a sesquiterpene dilactone isolated from several Asteraceae family <i>Mikania</i> sp. plants. Sesquiterpene dilactone is a traditional medicine for treating ailments, such as flu, cardiovascular diseases, bacterial infections, and other blood disorders. It is used as a cytotoxic agent as well. The need of the hour is potent chemotherapeutic agents with cytotoxic effects inhibition of proliferation and activation of apoptotic machinery. Recently, ERK inhibitors are used in clinics as anticancer agents. Thus, in this study, we synthesized 22-mikanolide derivatives that elucidated to be potent antileukemic agents <i>in vitro</i>. However, a bioactive mikanolide derivative, 3g, was found with potent antileukemic activity, through the Ras/Raf/MEK/ERK pathway. It can arrest the cell cycle by inhibiting phosphorylation of CDC25C, triggering apoptosis, and promoting DNA and mitochondrial damage, thus suggesting it as a potential chemotherapeutic agent for leukemia patients."], "CopyrightInformation": "Copyright \u00a9 2022 Rao, Xie, Varier, Huang, Song, Yang, Qiu, Huang, Li, Gajendran, Li and Liu."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Rao", "ForeName": "Qing", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Xie", "ForeName": "Kaiqiang", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Varier", "ForeName": "Krishnapriya M", "Initials": "KM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Huang", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Song", "ForeName": "Jingrui", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Yang", "ForeName": "Jue", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Qiu", "ForeName": "Jianfei", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Huang", "ForeName": "Yubing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Li", "ForeName": "Yan", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}, {"Identifier": [], "Affiliation": "School of Pharmaceutical Sciences, Guizhou Medical University, Guiyang, China."}], "LastName": "Gajendran", "ForeName": "Babu", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Li", "ForeName": "Yanmei", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory for Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "The Key Laboratory of Chemistry for Natural Products of Guizhou Province and Chinese Academic of Sciences, Guiyang, China."}], "LastName": "Liu", "ForeName": "Sheng", "Initials": "S"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Abrams S. L., Steelman L. S., Shelton J. G., Wong E. W., Chappell W. H., B\u00e4secke J., et al. (2010). The Raf/MEK/ERK Pathway Can Govern Drug Resistance, Apoptosis and Sensitivity to Targeted Therapy. Cell Cycle 9 (9), 1781\u20131791. 10.4161/cc.9.9.11483", "ArticleIdList": ["10.4161/cc.9.9.11483", "PMC3781182", "20436278"]}, {"Citation": "Adams J. M. (2003). Ways of Dying: Multiple Pathways to Apoptosis. Genes Dev. 17 (20), 2481\u20132495. 10.1101/gad.1126903", "ArticleIdList": ["10.1101/gad.1126903", "14561771"]}, {"Citation": "Ahearn I. M., Haigis K., Bar-Sagi D., Philips M. R. (2011). Regulating the Regulator: post-translational Modification of RAS. Nat. Rev. Mol. Cell Biol 13 (1), 39\u201351. 10.1038/nrm3255", "ArticleIdList": ["10.1038/nrm3255", "PMC3879958", "22189424"]}, {"Citation": "Ahmed M., Rahman M. T., Alimuzzaman M., Shilpi J. A. (2001). Analgesic Sesquiterpene Dilactone from Mikania Cordata. Fitoterapia 72 (8), 919\u2013921. 10.1016/s0367-326x(01)00318-5", "ArticleIdList": ["10.1016/s0367-326x(01)00318-5", "11731117"]}, {"Citation": "Al Bitar S., Gali-Muhtasib H. (2019). The Role of the Cyclin Dependent Kinase Inhibitor P21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics. Cancers (Basel) 11 (10), 1475. 10.3390/cancers11101475", "ArticleIdList": ["10.3390/cancers11101475", "PMC6826572", "31575057"]}, {"Citation": "Anjum R., Blenis J. (2008). The RSK Family of Kinases: Emerging Roles in Cellular Signalling. Nat. Rev. Mol. Cell Biol 9 (10), 747\u2013758. 10.1038/nrm2509", "ArticleIdList": ["10.1038/nrm2509", "18813292"]}, {"Citation": "Bagnoli M., Canevari S., Mezzanzanica D. (2010). Cellular FLICE-Inhibitory Protein (C-FLIP) Signalling: a Key Regulator of Receptor-Mediated Apoptosis in Physiologic Context and in Cancer. Int. J. Biochem. Cell Biol 42, 210\u2013213. 10.1016/j.biocel.2009.11.015", "ArticleIdList": ["10.1016/j.biocel.2009.11.015", "19932761"]}, {"Citation": "Ben-Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. (1986). The Chronic Myelogenous Leukemia-specific P210 Protein Is the Product of the Bcr/abl Hybrid Gene. Science 233 (4760), 212\u2013214. 10.1126/science.3460176", "ArticleIdList": ["10.1126/science.3460176", "3460176"]}, {"Citation": "Bohlmann F., Tsankova E., King R. M., Robinson H. (1984). Five Mikanolide Derivatives from Mikania Cynanchifolia and Their Biogenetic Relationships. Phytochemistry 23 (5), 1099\u20131101. 10.1016/S0031-9422(00)82617-5", "ArticleIdList": ["10.1016/S0031-9422(00)82617-5"]}, {"Citation": "Branford S., Rudzki Z., Walsh S., Grigg A., Arthur C., Taylor K., et al. (2002). High Frequency of point Mutations Clustered within the Adenosine Triphosphate-Binding Region of BCR/ABL in Patients with Chronic Myeloid Leukemia or Ph-Positive Acute Lymphoblastic Leukemia Who Develop Imatinib (STI571) Resistance. Blood 99 (9), 3472\u20133475. 10.1182/blood.v99.9.3472", "ArticleIdList": ["10.1182/blood.v99.9.3472", "11964322"]}, {"Citation": "Chang F., Steelman L. S., Lee J. T., Shelton J. G., Navolanic P. M., Blalock W. L., et al. (2003). Signal Transduction Mediated by the Ras/Raf/MEK/ERK Pathway from Cytokine Receptors to Transcription Factors: Potential Targeting for Therapeutic Intervention. Leukemia 17 (7), 1263\u20131293. 10.1038/sj.leu.2402945", "ArticleIdList": ["10.1038/sj.leu.2402945", "12835716"]}, {"Citation": "Dai D. F., Chiao Y. A., Marcinek D. J., Szeto H. H., Rabinovitch P. S. (2014). Mitochondrial Oxidative Stress in Aging and Healthspan. Longev Healthspan 3, 6. 10.1186/2046-2395-3-6", "ArticleIdList": ["10.1186/2046-2395-3-6", "PMC4013820", "24860647"]}, {"Citation": "Facey P. C., Pascoe K. O., Porter R. B., Jones A. D. (1999). Investigation of Plants Used in Jamaican Folk Medicine for Anti-bacterial Activity. J. Pharm. Pharmacol. 51 (12), 1455\u20131460. 10.1211/0022357991777119", "ArticleIdList": ["10.1211/0022357991777119", "10678503"]}, {"Citation": "Fulda S., Galluzzi L., Kroemer G. (2010). Targeting Mitochondria for Cancer Therapy. Nat. Rev. Drug Discov. 9 (6), 447\u2013464. 10.1038/nrd3137", "ArticleIdList": ["10.1038/nrd3137", "20467424"]}, {"Citation": "Gajendran B., Durai P., Madhu Varier K., Chinnasamy A. (2020a). A Novel Phytosterol Isolated from Datura Inoxia, RinoxiaB Is a Potential Cure colon Cancer Agent by Targeting BAX/Bcl2 Pathway. Bioorg. Med. Chem. 28 (2), 115242. 10.1016/j.bmc.2019.115242", "ArticleIdList": ["10.1016/j.bmc.2019.115242", "31866271"]}, {"Citation": "Gajendran B., Varier K. M., Liu W., Wang C., Sample K. M., Zacksenhaus E., et al. (2020b). A C21-Steroidal Derivative Suppresses T-Cell Lymphoma in Mice by Inhibiting SIRT3 via SAP18-SIN3. Commun. Biol. 3 (1), 732. 10.1038/s42003-020-01458-3", "ArticleIdList": ["10.1038/s42003-020-01458-3", "PMC7713351", "33273692"]}, {"Citation": "Giordano O. S., Guerreiro E., Pestchanker M. J., Guzman J., Pastor D., Guardia T. (1990). The Gastric Cytoprotective Effect of Several Sesquiterpene Lactones. J. Nat. Prod. 53 (4), 803\u2013809. 10.1021/np50070a004", "ArticleIdList": ["10.1021/np50070a004", "2095374"]}, {"Citation": "Gutierrez A. B., Oberti J. C., Kulanthaivel P., Herz W. (1985). Sesquiterpene Lactones and Diterpenes from Mikania Periplocifolia. Phytochemistry 24, 2967\u20132971. 10.1016/0031-9422(85)80037-6", "ArticleIdList": ["10.1016/0031-9422(85)80037-6"]}, {"Citation": "Guzman M. L., Rossi R. M., Karnischky L., Li X., Peterson D. R., Howard D. S., et al. (2005). The Sesquiterpene Lactone Parthenolide Induces Apoptosis of Human Acute Myelogenous Leukemia Stem and Progenitor Cells. Blood 105 (11), 4163\u20134169. 10.1182/blood-2004-10-4135", "ArticleIdList": ["10.1182/blood-2004-10-4135", "PMC1895029", "15687234"]}, {"Citation": "Hanahan D., Weinberg R. A. (2000). The Hallmarks of Cancer. Cell 100 (1), 57\u201370. 10.1016/s0092-8674(00)81683-9", "ArticleIdList": ["10.1016/s0092-8674(00)81683-9", "10647931"]}, {"Citation": "Hu M., Varier K. M., Li Z., Qin X., Rao Q., Song J., et al. (2021). A Natural Acylphloroglucinol Triggered Antiproliferative Possessions in HEL Cells by Impeding STAT3 Signaling and Attenuating Angiogenesis in Transgenic Zebrafish Model. Biomed. Pharmacother. 141, 111877. 10.1016/j.biopha.2021.111877", "ArticleIdList": ["10.1016/j.biopha.2021.111877", "34323693"]}, {"Citation": "Hug H., Sarre T. F. (1993). Protein Kinase C Isoenzymes: Divergence in Signal Transduction? Biochem. J. 291 (Pt 2), 329\u2013343. 10.1042/bj2910329", "ArticleIdList": ["10.1042/bj2910329", "PMC1132529", "8484714"]}, {"Citation": "Indran I. R., Tufo G., Pervaiz S., Brenner C. (2011). Recent Advances in Apoptosis, Mitochondria and Drug Resistance in Cancer Cells. Biochim. Biophys. Acta 1807 (6), 735\u2013745. 10.1016/j.bbabio.2011.03.010", "ArticleIdList": ["10.1016/j.bbabio.2011.03.010", "21453675"]}, {"Citation": "Jackson P., Baltimore D. (1989). N-terminal Mutations Activate the Leukemogenic Potential of the Myristoylated Form of C-Abl. EMBO J. 8 (2), 449\u2013456. 10.1002/j.1460-2075.1989.tb03397.x", "ArticleIdList": ["10.1002/j.1460-2075.1989.tb03397.x", "PMC400826", "2542016"]}, {"Citation": "Knight T., Irving J. A. (2014). Ras/Raf/MEK/ERK Pathway Activation in Childhood Acute Lymphoblastic Leukemia and its Therapeutic Targeting. Front. Oncol. 4, 160. 10.3389/fonc.2014.00160", "ArticleIdList": ["10.3389/fonc.2014.00160", "PMC4067595", "25009801"]}, {"Citation": "Li Y., Li J., Li Y., Wang X. X., Cao A. C. (2013). Antimicrobial Constituents of the Leaves of Mikania Micrantha H. B. K. PLoS One 8 (10), e76725. 10.1371/journal.pone.0076725", "ArticleIdList": ["10.1371/journal.pone.0076725", "PMC3788719", "24098556"]}, {"Citation": "Liu J., Zhang Y., Huang H., Lei X., Tang G., Cao X., et al. (2021). Recent Advances in Bcr\u2010Abl Tyrosine Kinase Inhibitors for Overriding T315I Mutation. Chem. Biol. Drug Des. 97 (3), 649\u2013664. 10.1111/cbdd.13801", "ArticleIdList": ["10.1111/cbdd.13801", "33034143"]}, {"Citation": "Liu K., Zheng M., Lu R., Du J., Zhao Q., Li Z., et al. (2020). The Role of CDC25C in Cell Cycle Regulation and Clinical Cancer Therapy: a Systematic Review. Cancer Cell Int 20, 213. 10.1186/s12935-020-01304-w", "ArticleIdList": ["10.1186/s12935-020-01304-w", "PMC7268735", "32518522"]}, {"Citation": "Ma L., Zhang J., Wang X., Yang J., Guo L., Wang X., et al. (2021). Design and Synthesis of Diosgenin Derivatives as Apoptosis Inducers through Mitochondria-Related Pathways. Eur. J. Med. Chem. 217, 113361. 10.1016/j.ejmech.2021.113361", "ArticleIdList": ["10.1016/j.ejmech.2021.113361", "33740546"]}, {"Citation": "Maiti A., Franquiz M. J., Ravandi F., Cortes J. E., Jabbour E. J., Sasaki K., et al. (2020). Venetoclax and BCR-ABL Tyrosine Kinase Inhibitor Combinations: Outcome in Patients with Philadelphia Chromosome-Positive Advanced Myeloid Leukemias. Acta Haematol. 143 (6), 567\u2013573. 10.1159/000506346", "ArticleIdList": ["10.1159/000506346", "PMC7839068", "32289808"]}, {"Citation": "McCubrey J. A., Abrams S. L., Ligresti G., Misaghian N., Wong E. W., Steelman L. S., et al. (2008a). Involvement of P53 and Raf/MEK/ERK Pathways in Hematopoietic Drug Resistance. Leukemia 22 (11), 2080\u20132090. 10.1038/leu.2008.207", "ArticleIdList": ["10.1038/leu.2008.207", "18685611"]}, {"Citation": "McCubrey J. A., Steelman L. S., Abrams S. L., Bertrand F. E., Ludwig D. E., B\u00e4secke J., et al. (2008b). Targeting Survival Cascades Induced by Activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT Pathways for Effective Leukemia Therapy. Leukemia 22 (4), 708\u2013722. 10.1038/leu.2008.27", "ArticleIdList": ["10.1038/leu.2008.27", "18337766"]}, {"Citation": "McCubrey J. A., Steelman L. S., Chappell W. H., Abrams S. L., Wong E. W., Chang F., et al. (2007). Roles of the Raf/MEK/ERK Pathway in Cell Growth, Malignant Transformation and Drug Resistance. Biochim. Biophys. Acta 1773 (8), 1263\u20131284. 10.1016/j.bbamcr.2006.10.001", "ArticleIdList": ["10.1016/j.bbamcr.2006.10.001", "PMC2696318", "17126425"]}, {"Citation": "McCubrey J. A., Steelman L. S., Kempf C. R., Chappell W. H., Abrams S. L., Stivala F., et al. (2011). Therapeutic Resistance Resulting from Mutations in Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Signaling Pathways. J. Cell Physiol 226 (11), 2762\u20132781. 10.1002/jcp.22647", "ArticleIdList": ["10.1002/jcp.22647", "21302297"]}, {"Citation": "Morris G. M., Huey R., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., et al. (2009). AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility. J. Comput. Chem. 30 (16), 2785\u20132791. 10.1002/jcc.21256", "ArticleIdList": ["10.1002/jcc.21256", "PMC2760638", "19399780"]}, {"Citation": "Musacchio A., Saraste M., Wilmanns M. (1994). High-resolution crystal Structures of Tyrosine Kinase SH3 Domains Complexed with Proline-Rich Peptides. Nat. Struct. Biol. 1 (8), 546\u2013551. 10.1038/nsb0894-546", "ArticleIdList": ["10.1038/nsb0894-546", "7664083"]}, {"Citation": "Nakshatri H., Rice S. E., Bhat-Nakshatri P. (2004). Antitumor Agent Parthenolide Reverses Resistance of Breast Cancer Cells to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand through Sustained Activation of C-Jun N-Terminal Kinase. Oncogene 23 (44), 7330\u20137344. 10.1038/sj.onc.1207995", "ArticleIdList": ["10.1038/sj.onc.1207995", "15286701"]}, {"Citation": "Overduin M., Rios C. B., Mayer B. J., Baltimore D., Cowburn D. (1992). Three-dimensional Solution Structure of the Src Homology 2 Domain of C-Abl. Cell 70 (4), 697\u2013704. 10.1016/0092-8674(92)90437-h", "ArticleIdList": ["10.1016/0092-8674(92)90437-h", "1505033"]}, {"Citation": "Pickman A. K. (1986). Biological Activity of Sesquiterpene Lactones. Biochem. Syst. Ecol. 14, 255\u2013281. 10.1016/0305-1978(86)90101-8", "ArticleIdList": ["10.1016/0305-1978(86)90101-8"]}, {"Citation": "Redon C., Pilch D., Rogakou E., Sedelnikova O., Newrock K., Bonner W. (2002). Histone H2A Variants H2AX and H2AZ. Curr. Opin. Genet. Dev. 12 (2), 162\u2013169. 10.1016/s0959-437x(02)00282-4", "ArticleIdList": ["10.1016/s0959-437x(02)00282-4", "11893489"]}, {"Citation": "Redza-Dutordoir M., Averill-Bates D. A. (2016). Activation of Apoptosis Signalling Pathways by Reactive Oxygen Species. Biochim. Biophys. Acta 1863 (12), 2977\u20132992. 10.1016/j.bbamcr.2016.09.012", "ArticleIdList": ["10.1016/j.bbamcr.2016.09.012", "27646922"]}, {"Citation": "Rogakou E. P., Pilch D. R., Orr A. H., Ivanova V. S., Bonner W. M. (1998). DNA Double-Stranded Breaks Induce Histone H2AX Phosphorylation on Serine 139. J. Biol. Chem. 273 (10), 5858\u20135868. 10.1074/jbc.273.10.5858", "ArticleIdList": ["10.1074/jbc.273.10.5858", "9488723"]}, {"Citation": "Steelman L. S., Abrams S. L., Shelton J. G., Chappell W. H., B\u00e4secke J., Stivala F., et al. (2010). Dominant Roles of the Raf/MEK/ERK Pathway in Cell Cycle Progression, Prevention of Apoptosis and Sensitivity to Chemotherapeutic Drugs. Cell Cycle 9 (8), 1629\u20131638. 10.4161/cc.9.8.11487", "ArticleIdList": ["10.4161/cc.9.8.11487", "PMC3781180", "20372086"]}, {"Citation": "Steelman L. S., Abrams S. L., Whelan J., Bertrand F. E., Ludwig D. E., B\u00e4secke J., et al. (2008). Contributions of the Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT Pathways to Leukemia. Leukemia 22 (4), 686\u2013707. 10.1038/leu.2008.26", "ArticleIdList": ["10.1038/leu.2008.26", "18337767"]}, {"Citation": "Sun C., Wang G., Wrighton K. H., Lin H., Songyang Z., Feng X. H., et al. (2016). Regulation of p27Kip1 Phosphorylation and G1 Cell Cycle Progression by Protein Phosphatase PPM1G. Am. J. Cancer Res. 6 (10), 2207\u20132220.", "ArticleIdList": ["PMC5088286", "27822412"]}, {"Citation": "Vaidya S., Vundinti B. R., Shanmukhaiah C., Chakrabarti P., Ghosh K. (2015). Evolution of BCR/ABL Gene Mutation in CML Is Time Dependent and Dependent on the Pressure Exerted by Tyrosine Kinase Inhibitor. PloS one 10 (1), e0114828. 10.1371/journal.pone.0114828", "ArticleIdList": ["10.1371/journal.pone.0114828", "PMC4309587", "25629972"]}, {"Citation": "Varier K. M., Sumathi T. (2019). Hinokitiol Offers Neuroprotection against 6-OHDA-Induced Toxicity in SH-SY5Y Neuroblastoma Cells by Downregulating mRNA Expression of MAO/\u03b1-Synuclein/LRRK2/PARK7/PINK1/PTEN Genes. Neurotox Res. 35 (4), 945\u2013954. 10.1007/s12640-018-9988-x", "ArticleIdList": ["10.1007/s12640-018-9988-x", "30569287"]}, {"Citation": "Varier K. M., Thangarajan S., Chinnasamy A., Balakrishnan G., Paulose R. (2017). Comparative Analysis of Potentiality of Esculin and Hinokitol (\u0392-Thujaplicin) as Anti-parkinsonism Drugs: a Pilot In Silico Study. Int. J. Pharm. Pharm. Sci. 9, 108\u2013115. 10.22159/ijpps.2017v9i1.15340", "ArticleIdList": ["10.22159/ijpps.2017v9i1.15340"]}, {"Citation": "Wan Y. L., Wang Y., Liu B. C., Liu X., Gong X. Y., Zhao X. L., et al. (2016). Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 37 (10), 886\u2013891. 10.3760/cma.j.issn.0253-2727.2016.10.014", "ArticleIdList": ["10.3760/cma.j.issn.0253-2727.2016.10.014", "PMC7364881", "27801322"]}, {"Citation": "Willis S. G., Lange T., Demehri S., Otto S., Crossman L., Niederwieser D., et al. (2005). High-sensitivity Detection of BCR-ABL Kinase Domain Mutations in Imatinib-Naive Patients: Correlation with Clonal Cytogenetic Evolution but Not Response to Therapy. Blood 106 (6), 2128\u20132137. 10.1182/blood-2005-03-1036", "ArticleIdList": ["10.1182/blood-2005-03-1036", "15914554"]}, {"Citation": "Xiaofei E., Kowalik T. F. (2014). The DNA Damage Response Induced by Infection with Human Cytomegalovirus and Other Viruses. Viruses 6 (5), 2155\u20132185. 10.3390/v6052155", "ArticleIdList": ["10.3390/v6052155", "PMC4036536", "24859341"]}, {"Citation": "Ysrael M. C., Croft K. D. (1990). Inhibition of Leukotriene and Platelet Activating Factor Synthesis in Leukocytes by the Sesquiterpene Lactone Scandenolide. Planta Med. 56 (3), 268\u2013270. 10.1055/s-2006-960953", "ArticleIdList": ["10.1055/s-2006-960953", "2168055"]}, {"Citation": "Zhang S., Lin Z. N., Yang C. F., Shi X., Ong C. N., Shen H. M. (2004). Suppressed NF-kappaB and Sustained JNK Activation Contribute to the Sensitization Effect of Parthenolide to TNF-Alpha-Induced Apoptosis in Human Cancer Cells. Carcinogenesis 25 (11), 2191\u20132199. 10.1093/carcin/bgh234", "ArticleIdList": ["10.1093/carcin/bgh234", "15256485"]}, {"Citation": "Zhuang S. H., Hao C. Q., Feng J. T., Zhang X. (20102010). Active Antifungal Components of Mikania Micrantha H. B. K. J. Zhejiang Univ. (Agriculture Life Sciences) 36, 293\u2013298."}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "11", "Day": "18"}, {"Year": "2022", "Month": "4", "Day": "6"}, {"Year": "2022", "Month": "6", "Day": "20", "Hour": "3", "Minute": "51"}, {"Year": "2022", "Month": "6", "Day": "21", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "21", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "5", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["35721186", "PMC9205396", "10.3389/fphar.2022.809551", "809551"]}}], "PubmedBookArticle": []}